{"transactions":[{"id":3167802,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":329347,"derivative":{"exercise_price":5.2,"exercise_date":"2012-04-01","expiration_date":"2021-10-26","underlying":"Common Stock","underlying_shares":213},"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167801,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":329560,"derivative":{"exercise_price":5.19,"exercise_date":"2012-03-01","expiration_date":"2022-02-16","underlying":"Common Stock","underlying_shares":830},"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167800,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":330390,"derivative":{"exercise_price":4.75,"exercise_date":"2013-10-01","expiration_date":"2023-09-21","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167799,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":1454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":331590,"derivative":{"exercise_price":14.54,"exercise_date":"2014-03-01","expiration_date":"2024-02-06","underlying":"Common Stock","underlying_shares":1454},"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167798,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":333044,"derivative":{"exercise_price":7.75,"exercise_date":"2015-04-06","expiration_date":"2025-03-06","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167797,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-27","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":333544,"derivative":{"exercise_price":5.19,"exercise_date":"2012-03-01","expiration_date":"2020-02-16","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167796,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":700,"price":40,"value":28000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to\n$40.01, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":850730,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167795,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":204,"price":40,"value":8160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."}],"balance_after":851430,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167794,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":213,"price":40,"value":8520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."}],"balance_after":851634,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167793,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":830,"price":40,"value":33200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to\n$40.01, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":851847,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167792,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":1200,"price":40,"value":48000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."}],"balance_after":852677,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167791,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":1454,"price":40,"value":58160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to\n$40.01, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":853877,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167790,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":500,"price":40,"value":20000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."}],"balance_after":855331,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167789,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":213,"price":5.2,"value":1107.6,"ownership":{"direct":true},"balance_after":855831,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167788,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":830,"price":5.19,"value":4307.7,"ownership":{"direct":true},"balance_after":855618,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167787,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":1200,"price":4.75,"value":5700.0,"ownership":{"direct":true},"balance_after":854788,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167786,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":1454,"price":14.54,"value":21141.16,"ownership":{"direct":true},"balance_after":853588,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167785,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":500,"price":7.75,"value":3875.0,"ownership":{"direct":true},"balance_after":852134,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167784,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-27","kind":"sale","acquired":false,"shares":100,"price":40,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."}],"balance_after":851634,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167783,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-27","kind":"sale","acquired":false,"shares":200,"price":40,"value":8000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended."}],"balance_after":851734,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3167782,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-29T23:19:47.000Z","date":"2020-04-27","kind":"exercise","acquired":true,"shares":200,"price":5.19,"value":1038.0,"ownership":{"direct":true},"balance_after":851934,"source":{"system":"sec-edgar","filing":"0001209191-20-026230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120026230/doc4.xml","form_type":"4"}},{"id":3172054,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":333744,"derivative":{"exercise_price":14.54,"exercise_date":"2014-03-01","expiration_date":"2024-02-06","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172053,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"exercise","acquired":false,"shares":3456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":339044,"derivative":{"exercise_price":5.2,"exercise_date":"2012-04-01","expiration_date":"2021-10-26","underlying":"Common Stock","underlying_shares":3456},"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172052,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"exercise","acquired":false,"shares":3700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":342500,"derivative":{"exercise_price":5.19,"exercise_date":"2012-03-01","expiration_date":"2022-02-16","underlying":"Common Stock","underlying_shares":3700},"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172051,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"exercise","acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":346200,"derivative":{"exercise_price":4.75,"exercise_date":"2013-10-01","expiration_date":"2023-09-21","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172050,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":3805,"price":40,"value":152200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.01, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":851734,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172049,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":3454,"price":40,"value":138160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.01, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":855539,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172048,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":5300,"price":40,"value":212000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.02, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4"}],"balance_after":858993,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172047,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":3456,"price":40,"value":138240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.01, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":864293,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172046,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":3700,"price":40,"value":148000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.02, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4"}],"balance_after":867749,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172045,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":3800,"price":40,"value":152000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.01, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":871449,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172044,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"exercise","acquired":true,"shares":5300,"price":14.54,"value":77062.0,"ownership":{"direct":true},"balance_after":875249,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172043,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"exercise","acquired":true,"shares":3456,"price":5.2,"value":17971.2,"ownership":{"direct":true},"balance_after":869949,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172042,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"exercise","acquired":true,"shares":3700,"price":5.19,"value":19203.0,"ownership":{"direct":true},"balance_after":866493,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3172041,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-04-22T23:00:35.000Z","date":"2020-04-20","kind":"exercise","acquired":true,"shares":3800,"price":4.75,"value":18050.0,"ownership":{"direct":true},"balance_after":862793,"source":{"system":"sec-edgar","filing":"0001209191-20-025382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120025382/doc4.xml","form_type":"4"}},{"id":3315663,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-08T23:35:40.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":1300,"price":60.99,"value":79287.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.92 to $61.04, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":858993,"source":{"system":"sec-edgar","filing":"0001209191-20-002617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120002617/doc4.xml","form_type":"4"}},{"id":3315662,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-08T23:35:40.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":22466,"price":60.37,"value":1356272.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.91 to $60.91, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":860293,"source":{"system":"sec-edgar","filing":"0001209191-20-002617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120002617/doc4.xml","form_type":"4"}},{"id":3315661,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-08T23:35:40.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":11847,"price":59.57,"value":705725.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.90 to $59.90, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":882759,"source":{"system":"sec-edgar","filing":"0001209191-20-002617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120002617/doc4.xml","form_type":"4"}},{"id":3324909,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-03T23:04:44.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments."}],"balance_after":894606,"source":{"system":"sec-edgar","filing":"0001209191-20-001356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120001356/doc4.xml","form_type":"4"}},{"id":3624683,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-02T01:42:49.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":350000,"derivative":{"exercise_price":2.01,"exercise_date":"2013-06-01","expiration_date":"2023-05-06","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001209191-19-015284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119015284/doc4.xml","form_type":"4"}},{"id":3624682,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-02T01:42:49.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":42500,"price":19.99,"value":849575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.98 to $20.01, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":644606,"source":{"system":"sec-edgar","filing":"0001209191-19-015284","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119015284/doc4.xml","form_type":"4"}},{"id":3624681,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-03-02T01:42:49.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":42500,"price":2.01,"value":85425.0,"ownership":{"direct":true},"balance_after":687106,"source":{"system":"sec-edgar","filing":"0001209191-19-015284","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119015284/doc4.xml","form_type":"4"}},{"id":3630092,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-28T00:08:42.000Z","date":"2019-02-25","kind":"exercise","acquired":false,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":392500,"derivative":{"exercise_price":2.01,"exercise_date":"2013-06-01","expiration_date":"2023-05-06","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001209191-19-014235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119014235/doc4.xml","form_type":"4"}},{"id":3630091,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-28T00:08:42.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":42500,"price":18.98,"value":806650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.98 to $19.00, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":644606,"source":{"system":"sec-edgar","filing":"0001209191-19-014235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119014235/doc4.xml","form_type":"4"}},{"id":3630090,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-28T00:08:42.000Z","date":"2019-02-25","kind":"exercise","acquired":true,"shares":42500,"price":2.01,"value":85425.0,"ownership":{"direct":true},"balance_after":687106,"source":{"system":"sec-edgar","filing":"0001209191-19-014235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119014235/doc4.xml","form_type":"4"}},{"id":3647578,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-21T01:09:46.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":435000,"derivative":{"exercise_price":2.01,"exercise_date":"2013-06-01","expiration_date":"2023-05-06","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001209191-19-011829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119011829/doc4.xml","form_type":"4"}},{"id":3647577,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-21T01:09:46.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":42500,"price":17.98,"value":764150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.98 to $18.00, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":644606,"source":{"system":"sec-edgar","filing":"0001209191-19-011829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119011829/doc4.xml","form_type":"4"}},{"id":3647576,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-21T01:09:46.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":42500,"price":2.01,"value":85425.0,"ownership":{"direct":true},"balance_after":687106,"source":{"system":"sec-edgar","filing":"0001209191-19-011829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119011829/doc4.xml","form_type":"4"}},{"id":3647575,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-21T01:09:46.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":26250,"price":17.67,"value":463837.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.61 to $17.79, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":644606,"source":{"system":"sec-edgar","filing":"0001209191-19-011829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119011829/doc4.xml","form_type":"4"}},{"id":3664242,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":477500,"derivative":{"exercise_price":2.01,"exercise_date":"2013-06-01","expiration_date":"2023-05-06","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664241,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-11","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":520000,"derivative":{"exercise_price":2.62,"exercise_date":"2012-10-01","expiration_date":"2022-09-28","underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664240,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-08","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":531667,"derivative":{"exercise_price":2.62,"exercise_date":"2012-10-01","expiration_date":"2022-09-28","underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664239,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-12","kind":"sale","acquired":false,"shares":42500,"price":17.06,"value":725050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.03 to $17.21, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":670856,"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664238,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":42500,"price":2.01,"value":85425.0,"ownership":{"direct":true},"balance_after":713356,"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664237,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-11","kind":"sale","acquired":false,"shares":57000,"price":16.48,"value":939360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":670856,"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664236,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-11","kind":"sale","acquired":false,"shares":97167,"price":15.66,"value":1521635.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.23 to $16.23, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":727856,"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664235,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-11","kind":"exercise","acquired":true,"shares":11667,"price":2.62,"value":30567.54,"ownership":{"direct":true},"balance_after":825023,"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664234,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-08","kind":"sale","acquired":false,"shares":46167,"price":15.34,"value":708201.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.48 to $15.48, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":813356,"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3664233,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-13T01:58:59.000Z","date":"2019-02-08","kind":"exercise","acquired":true,"shares":11667,"price":2.62,"value":30567.54,"ownership":{"direct":true},"balance_after":859523,"source":{"system":"sec-edgar","filing":"0001209191-19-009534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119009534/doc4.xml","form_type":"4"}},{"id":3671073,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-08T01:35:46.000Z","date":"2019-02-05","kind":"sale","acquired":false,"shares":22500,"price":14.48,"value":325800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":847856,"source":{"system":"sec-edgar","filing":"0001209191-19-008329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119008329/doc4.xml","form_type":"4"}},{"id":3680361,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-02T00:51:49.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":28500,"price":13.85,"value":394725.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.62 to $14.14, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":870356,"source":{"system":"sec-edgar","filing":"0001209191-19-006623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119006623/doc4.xml","form_type":"4"}},{"id":3688660,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-25T01:53:24.000Z","date":"2019-01-23","kind":"sale","acquired":false,"shares":17500,"price":13.15,"value":230125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.28, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":898856,"source":{"system":"sec-edgar","filing":"0001209191-19-005261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119005261/doc4.xml","form_type":"4"}},{"id":3688659,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-25T01:53:24.000Z","date":"2019-01-22","kind":"sale","acquired":false,"shares":152000,"price":13.59,"value":2065680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.30 to $14.30, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":916356,"source":{"system":"sec-edgar","filing":"0001209191-19-005261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119005261/doc4.xml","form_type":"4"}},{"id":3694966,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-17T01:18:56.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":543334,"derivative":{"exercise_price":6.2,"exercise_date":"2009-09-28","expiration_date":"2019-09-28","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-19-004003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/doc4.xml","form_type":"4"}},{"id":3694965,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-17T01:18:56.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":544334,"derivative":{"exercise_price":2.62,"exercise_date":"2012-10-01","expiration_date":"2022-09-28","underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001209191-19-004003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/doc4.xml","form_type":"4"}},{"id":3694964,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-17T01:18:56.000Z","date":"2019-01-14","kind":"sale","acquired":false,"shares":42666,"price":14.4,"value":614390.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.03 to $14.57, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":1068356,"source":{"system":"sec-edgar","filing":"0001209191-19-004003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/doc4.xml","form_type":"4"}},{"id":3694963,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-17T01:18:56.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":1000,"price":6.2,"value":6200.0,"ownership":{"direct":true},"balance_after":1111022,"source":{"system":"sec-edgar","filing":"0001209191-19-004003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/doc4.xml","form_type":"4"}},{"id":3694962,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-17T01:18:56.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":11666,"price":2.62,"value":30564.92,"ownership":{"direct":true},"balance_after":1110022,"source":{"system":"sec-edgar","filing":"0001209191-19-004003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119004003/doc4.xml","form_type":"4"}},{"id":3710960,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-04T00:53:29.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":20000,"price":11.98,"value":239600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.69 to $12.16, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":1098356,"source":{"system":"sec-edgar","filing":"0001209191-19-001472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119001472/doc4.xml","form_type":"4"}},{"id":3710959,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-04T00:53:29.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments."}],"balance_after":1118356,"source":{"system":"sec-edgar","filing":"0001209191-19-001472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119001472/doc4.xml","form_type":"4"}},{"id":4017469,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-06T01:48:45.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":20000,"price":6.73,"value":134600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units on 03/05/2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.65 to $6.77, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":908356,"source":{"system":"sec-edgar","filing":"0001209191-18-016994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118016994/doc4.xml","form_type":"4"}},{"id":4114698,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-01-04T00:25:45.000Z","date":"2018-01-01","kind":"sale","acquired":false,"shares":20000,"price":3.69,"value":73800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.  The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units on 01/01/2018."}],"balance_after":928356,"source":{"system":"sec-edgar","filing":"0001209191-18-001466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118001466/doc4.xml","form_type":"4"}},{"id":4114697,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-01-04T00:25:45.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments."}],"balance_after":948356,"source":{"system":"sec-edgar","filing":"0001209191-18-001466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118001466/doc4.xml","form_type":"4"}},{"id":4504993,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":149618,"kind":"person","name":"GIVEN BRUCE D","position":1,"cik":"0001219384","reported_name":"GIVEN BRUCE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-01-05T01:27:55.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment in January 2019."}],"balance_after":773356,"source":{"system":"sec-edgar","filing":"0001209191-17-001605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919117001605/doc4.xml","form_type":"4"}}]}